Most mRNA vaccine trials study infectious diseases
Ongoing Phase I–III trials testing mRNA vaccines, sorted by therapy area
Infectious diseases
70%
Oncology
12%
Immunology diseases
4.7%
Central nervous system diseases
2.7%
Other
10%
Infectious diseases
Oncology
Immunology diseases
Central nervous system diseases
Other
GlobalData
